GGrantIndex
← Leaderboards

Richard P Lifton

Yale University

$24,984,883
Attributed
$55,456,598
Total exposure
22
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $5.9M · FY200524
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$66,106,093 · 23

By mechanism

P50$17,651,227 · 6
UM1$17,034,503 · 2
U54$11,047,460 · 1
U01$5,928,659 · 1
T32$4,200,090 · 1
R01$3,988,665 · 3

Top collaborators

Most similar at Yale University

Same institution · by research overlap

Others in their field

Top investigators on “Genetic

Research focus

GeneticVariantMutationPhenotypeGenomicsGenesBaseTechnologyComplexTraitCohortPathway InteractionsGenomeSignal TransductionLinkExomeGenotypeMolecularGene DiscoveryMapsAffectCellsExome SequencingCollaborations

Grant awards (100)

Congenital Heart Disease Genetics and Clinical Outcomes$420,644
U01 · FY2024 · HL
Congenital Heart Disease Genetics and Clinical Outcomes$425,287
U01 · FY2023 · HL
Congenital Heart Disease Genetics and Clinical Outcomes$426,094
U01 · FY2022 · HL
Congenital Heart Disease Genetics and Clinical Outcomes$426,876
U01 · FY2021 · HL
Yale Center for Mendelian Genomics$2,425,542
UM1 · FY2020 · HG · contact PI
Congenital Heart Disease Genetics and Clinical Outcomes$449,284
U01 · FY2020 · HL
Yale Center for Mendelian Genomics$2,975,542
UM1 · FY2019 · HG · contact PI
Genetics and genomics of congenital heart disease and associated neurodevelopmental abnormalities$431,583
UM1 · FY2019 · HL
Yale Center for Mendelian Genomics$2,983,803
UM1 · FY2018 · HG · contact PI
Genetics and genomics of congenital heart disease and associated neurodevelopmental abnormalities$431,583
UM1 · FY2018 · HL
KINASES AND UBIQUITIN LIGASES IN THE REGULATION OF RENAL TRANSPORT$288,343
P01 · FY2018 · DK · contact PI
Yale Center for Mendelian Genomics$250,000
UM1 · FY2018 · HG · contact PI
Yale Center for Mendelian Genomics$2,991,825
UM1 · FY2017 · HG · contact PI
Genetics and genomics of congenital heart disease and associated neurodevelopmental abnormalities$431,583
UM1 · FY2017 · HL
Human Genetics and Clinical Research Core$299,698
P30 · FY2017 · DK · contact PI
KINASES AND UBIQUITIN LIGASES IN THE REGULATION OF RENAL TRANSPORT$296,182
P01 · FY2017 · DK · contact PI
Genomic Sunlight Dosimeters for Melanoma Prevention$160,848
P50 · FY2017 · CA
Yale Center for Mendelian Genomics$3,200,000
UM1 · FY2016 · HG · contact PI
Genomic Sunlight Dosimeters for Melanoma Prevention$1,022,551
P50 · FY2016 · CA
Discovery and fine mapping of susceptibility loci for IgA nephropathy$454,826
R01 · FY2016 · DK
Genetics and genomics of congenital heart disease and associated neurodevelopmental abnormalities$438,001
UM1 · FY2016 · HL
KINASES AND UBIQUITIN LIGASES IN THE REGULATION OF RENAL TRANSPORT$303,793
P01 · FY2016 · DK · contact PI
Human Genetics and Clinical Research Core$299,698
P30 · FY2016 · DK · contact PI
Yale Center for Mendelian Disorders$2,665,740
U54 · FY2015 · HG · contact PI
Genomic Sunlight Dosimeters for Melanoma Prevention$1,033,429
P50 · FY2015 · CA
Genetics and genomics of congenital heart disease and associated neurodevelopmental abnormalities$475,041
UM1 · FY2015 · HL
Discovery and fine mapping of susceptibility loci for IgA nephropathy$454,826
R01 · FY2015 · DK
Genetics and Genomics of Human Disease$319,828
T32 · FY2015 · HD · contact PI
KINASES AND UBIQUITIN LIGASES IN THE REGULATION OF RENAL TRANSPORT$311,180
P01 · FY2015 · DK · contact PI
Human Genetics and Clinical Research Core$299,698
P30 · FY2015 · DK · contact PI
Yale Center for Mendelian Disorders$2,696,444
U54 · FY2014 · HG · contact PI
Genomic Sunlight Dosimeters for Melanoma Prevention$1,021,612
P50 · FY2014 · CA
Genetic determinants of human heterotaxy and aortic arch malformation$691,355
U01 · FY2014 · HL
Discovery and fine mapping of susceptibility loci for IgA nephropathy$457,685
R01 · FY2014 · DK
KINASES AND UBIQUITIN LIGASES IN THE REGULATION OF RENAL TRANSPORT$318,353
P01 · FY2014 · DK · contact PI
Genetics and Genomics of Human Disease$317,451
T32 · FY2014 · HD · contact PI
Human Genetics and Clinical Research Core$299,698
P30 · FY2014 · DK · contact PI
Yale Center for Mendelian Disorders$75,000
U54 · FY2014 · HG · contact PI
Yale Center for Mendelian Disorders$2,643,825
U54 · FY2013 · HG · contact PI
Genomic Sunlight Dosimeters for Melanoma Prevention$1,110,673
P50 · FY2013 · CA
Genetic determinants of human heterotaxy and aortic arch malformation$673,385
U01 · FY2013 · HL
Discovery and fine mapping of susceptibility loci for IgA nephropathy$596,589
R01 · FY2013 · DK
Genetics and Genomics of Human Disease$314,094
T32 · FY2013 · HD · contact PI
Human Genetics and Clinical Research Core$299,698
P30 · FY2013 · DK · contact PI
Discovery and fine mapping of susceptibility loci for IgA nephropathy$100,000
R01 · FY2013 · DK
Yale Center for Mendelian Disorders$2,800,000
U54 · FY2012 · HG · contact PI
Genomic Sunlight Dosimeters for Melanoma Prevention$1,077,491
P50 · FY2012 · CA
Genetic determinants of human heterotaxy and aortic arch malformation$709,149
U01 · FY2012 · HL
Discovery and fine mapping of susceptibility loci for IgA nephropathy$618,227
R01 · FY2012 · DK
Genetics and Genomics of Human Disease$314,094
T32 · FY2012 · HD · contact PI
Yale Center for Mendelian Disorders$166,451
U54 · FY2012 · HG · contact PI
Genetic determinants of human heterotaxy and aortic arch malformation$718,094
U01 · FY2011 · HL
Genetics and Genomics of Human Disease$308,512
T32 · FY2011 · HD · contact PI
Genetic determinants of human heterotaxy and aortic arch malformation$719,294
U01 · FY2010 · HL
A GWAS for IgA Nephropathy, the Most Common form of Glomerulonephritis$498,760
RC1 · FY2010 · DK
Genetics and Genomics of Human Disease$301,807
T32 · FY2010 · HD · contact PI
A GWAS for IgA Nephropathy, the Most Common form of Glomerulonephritis$499,221
RC1 · FY2009 · DK
Genetics and Genomics of Human Disease$298,582
T32 · FY2009 · HD · contact PI
Genetic determinants of human heterotaxy and aortic arch malformation$269,197
U01 · FY2009 · HL
Genetics and Genomics of Human Disease$303,483
T32 · FY2008 · HD · contact PI
Mitochondrial Genetics, Diabetes and Metabolic Syndrome$292,593
P01 · FY2008 · DK · contact PI
GENETICS AND GENOMICS OF HUMAN DISEASE$294,708
T32 · FY2007 · HD · contact PI
Mitochondrial Genetics, Diabetes and Metabolic Syndrome$289,807
P01 · FY2007 · DK · contact PI
GENETICS AND GENOMICS OF HUMAN DISEASE$289,132
T32 · FY2006 · HD · contact PI
Mitochondrial Genetics, Diabetes and Metabolic Syndrome$174,581
P01 · FY2006 · DK · contact PI
SCOR: MOLECULAR GENETICS OF HYPERTENSION$2,037,048
P50 · FY2005 · HL
GENETICS OF HYPERTENSION IN THE FRAMINGHAM HEART STUDY$353,806
P50 · FY2005 · HL
GENETICS AND GENOMICS OF HUMAN DISEASE$297,485
T32 · FY2005 · HD
GENETICS, BARTTER'S, GITELMAN'S AND PHA-II$244,568
P50 · FY2005 · HL
Mitochondrial Genetics, Diabetes and Metabolic Syndrome$169,496
P01 · FY2005 · DK
GENETICS OF ELECTROLYTE IMBALANCES$22,054
M01 · FY2005 · RR
SCOR: MOLECULAR GENETICS OF HYPERTENSION$1,978,474
P50 · FY2004 · HL
GENETICS AND GENOMICS OF HUMAN DISEASE$424,470
T32 · FY2004 · HD
GENETICS OF HYPERTENSION IN THE FRAMINGHAM HEART STUDY$343,501
P50 · FY2004 · HL
GENETICS, BARTTER'S, GITELMAN'S AND PHA-II$237,445
P50 · FY2004 · HL
Regulation of EnaC by SGK and Inherited PHA1 mutations$232,237
P50 · FY2004 · HL
Mitochondrial Genetics, Diabetes and Metabolic Syndrome$164,560
P01 · FY2004 · DK
Genetics of Electrolyte Imbalances$120,232
M01 · FY2004 · RR
Core C-- Administrative Core$54,481
P50 · FY2004 · HL
SCOR: MOLECULAR GENETICS OF HYPERTENSION$1,921,605
P50 · FY2003 · HL
GENETICS AND GENOMICS OF HUMAN DISEASE$416,444
T32 · FY2003 · HD
SCOR: MOLECULAR GENETICS OF HYPERTENSION$1,866,393
P50 · FY2002 · HL
PATHOBIOLOGY OF CEREBRAL CAVERNOUS MALFORMATION$353,109
R01 · FY2002 · NS
GENETIC FACTORS FOR PROGRESSION OF HIV ASSOCIATED NEPHROPATHY$228,547
P01 · FY2002 · DK
GENETICS OF HYPERTENSION IN THE FRAMINGHAM HEART STUDY$0
P50 · FY2002 · HL
Genetic Studies Of Immunoglobulin A Nephropathy$0
P01 · FY2002 · DK
GENETICS, BARTTER'S, GITELMAN'S AND PHA-II$0
P50 · FY2002 · HL
SCOR: MOLECULAR GENETICS OF HYPERTENSION$1,941,776
P50 · FY2001 · HL
PATHOBIOLOGY OF CEREBRAL CAVERNOUS MALFORMATION$347,215
R01 · FY2001 · NS
GENETIC FACTORS FOR PROGRESSION OF HIV ASSOCIATED NEPHROPATHY$228,547
P01 · FY2001 · DK
GENETICS OF HYPERTENSION IN THE FRAMINGHAM HEART STUDY$0
P50 · FY2001 · HL
GENETIC STUDIES OF END STAGE RENAL DISEASE$0
M01 · FY2001 · RR
GENETICS, BARTTER'S, GITELMAN'S AND PHA-II$0
P50 · FY2001 · HL
INHERITED RENAL AND ELECTROLYTE DEFECTS IN HYPERTENSION$904,199
P50 · FY2000 · HL
PATHOBIOLOGY OF CEREBRAL CAVERNOUS MALFORMATION$341,493
R01 · FY2000 · NS
GENETIC FACTORS FOR PROGRESSION OF HIV ASSOCIATED NEPHROPATHY$287,668
P01 · FY2000 · DK
PATHOGENESIS AND SEQUELAE OF BARTTER &GORDON SYNDROMES$264,695
R01 · FY2000 · DK
GENETIC FACTORS FOR PROGRESSION OF HIV ASSOCIATED NEPHROPATHY$228,547
P01 · FY2000 · DK
GENETIC STUDIES OF LIDDLE'S SYNDROME$109,090
P50 · FY2000 · HL
GENETIC STUDIES OF END STAGE RENAL DISEASE$34,535
M01 · FY2000 · RR